Detalles de la búsqueda
1.
Gene Expression Patterns Associated with Survival in Glioblastoma.
Int J Mol Sci
; 25(7)2024 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38612480
2.
Using cfDNA and ctDNA as Oncologic Markers: A Path to Clinical Validation.
Int J Mol Sci
; 24(17)2023 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37686024
3.
Real-world data of off-label drug use in patients with actionable genomic alterations on next-generation sequencing.
Invest New Drugs
; 40(3): 643-649, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35038126
4.
A multicenter phase 1/2 study investigating the safety, pharmacokinetics, pharmacodynamics and efficacy of a small molecule antimetabolite, RX-3117, plus nab-paclitaxel in pancreatic adenocarcinoma.
Invest New Drugs
; 40(1): 81-90, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34417914
5.
Phase I Trial of Cemiplimab, Radiotherapy, Cyclophosphamide, and Granulocyte Macrophage Colony-Stimulating Factor in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
Oncologist
; 26(9): e1508-e1513, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33942954
6.
A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors.
Invest New Drugs
; 36(6): 1060-1071, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29980894
7.
Yttrium-90-Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy after Cytoreduction with ESHAP Chemotherapy in Patients with Relapsed Follicular Non-Hodgkin Lymphoma: Final Results of a Phase II Study.
Oncology
; 94(5): 274-280, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29471300
8.
Perceptions of control and unrealistic optimism in early-phase cancer trials.
J Med Ethics
; 44(2): 121-127, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28774957
9.
A phase 1/2 trial of ublituximab, a novel anti-CD20 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma or chronic lymphocytic leukaemia previously exposed to rituximab.
Br J Haematol
; 177(2): 243-253, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28220479
10.
Ublituximab (TG-1101), a novel glycoengineered anti-CD20 antibody, in combination with ibrutinib is safe and highly active in patients with relapsed and/or refractory chronic lymphocytic leukaemia: results of a phase 2 trial.
Br J Haematol
; 176(3): 412-420, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27982425
11.
Academic Cancer Center Phase I Program Development.
Oncologist
; 22(4): 369-374, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28314841
12.
Dispositional optimism and therapeutic expectations in early-phase oncology trials.
Cancer
; 122(8): 1238-46, 2016 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26882017
13.
Monoclonal antibodies as therapeutics in human malignancies.
Future Oncol
; 10(4): 609-36, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24754592
14.
Polyploidy in Cancer: Causal Mechanisms, Cancer-Specific Consequences, and Emerging Treatments.
Mol Cancer Ther
; 23(5): 638-647, 2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38315992
15.
ERBB2 (HER2) amplifications and co-occurring KRAS alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition.
Front Oncol
; 14: 1339302, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38406801
16.
Aurkin-A, a TPX2-aurora a small molecule inhibitor disrupts Alisertib-induced polyploidy in aggressive diffuse large B cell lymphoma.
Neoplasia
; 55: 101014, 2024 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38875929
17.
Advancing Inclusive Research (AIR) Site Alliance: Facilitating the inclusion of historically underrepresented people in oncology and ophthalmology clinical research.
Contemp Clin Trials
; 137: 107416, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38109966
18.
Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial.
Nat Med
; 2024 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38871975
19.
Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma: Southwest Oncology Group Study S0350.
Cancer
; 119(2): 371-9, 2013 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22833464
20.
Phase I trial of UNBS5162, a novel naphthalimide in patients with advanced solid tumors or lymphoma.
Int J Clin Oncol
; 18(5): 934-41, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23053399